Nuveen’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Nuveen’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-245,719	Closed	-$1.53M	–	3453
2021 Q3	$1.53M	Buy	245,719 +28,953	+13%	+$180K	﹤0.01%	2799
2021 Q2	$1.78M	Sell	216,766 -200,108	-48%	-$1.7M	﹤0.01%	2765
2021 Q1	$3.73M	Sell	416,874 -25,982	-6%	-$298K	﹤0.01%	2315
2020 Q4	$5.11M	Buy	442,856 +20,126	+5%	+$234K	﹤0.01%	2065
2020 Q3	$4.4M	Buy	422,730 +43,128	+11%	+$528K	﹤0.01%	1984
2020 Q2	$4.99M	Sell	379,602 -12,385	-3%	-$128K	﹤0.01%	1899
2020 Q1	$3.08M	Buy	391,987 +163,383	+71%	+$2.46M	﹤0.01%	1971
2019 Q4	$4.73M	Buy	228,604 +45,792	+25%	+$772K	﹤0.01%	2033
2019 Q3	$2.51M	Sell	182,812 -2,700	-1%	-$32K	﹤0.01%	2303
2019 Q2	$2.28M	Buy	+185,512	New	+$2.14M	﹤0.01%	2373

Nuveen's FLXN Position: Q4 2021 in Review

Nuveen sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 245,719 shares — an estimated $1.53M sold.

Nuveen first reported a position in FLXN in Q2 2019 and held it in 10 quarters. The position peaked at $5.11M in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Nuveen reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Nuveen sold 245,719 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1.53M.
Nuveen first reported a position in Flexion Therapeutics, Inc. in Q2 2019 and held it in 10 quarters.
Nuveen's Flexion Therapeutics, Inc. position peaked at $5.11M in Q4 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.